BioSpace News Archive

Business

Mustang Bio Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

As of September 30, 2017, Mustang’s cash and short-term investments (certificates of deposit) totaled $67.3 million, compared to $27.5 million at December 31, 2016, an increase of $39.8 million year-to-date.

November 14, 2017

·

9 min read

BioMidwest

Fresenius Kabi Announces Inductees to Blood Donation Hall of Fame

For nearly twenty years, Fresenius Kabi has partnered with blood centers across the country to recognize individuals who demonstrate unwavering commitment and passion for donating blood and encourage blood donation.

November 14, 2017

·

7 min read

Business

Rhythm Pharmaceuticals Reports Third Quarter 2017 Financial Results

As of September 30, 2017, cash, cash equivalents and short-term investments were $30.4 million, as compared to $10.5 million as of December 31, 2016.

November 14, 2017

·

9 min read

Deals

Monopar Therapeutics Announces Acquisition of GPX-150, a Broad Spectrum Phase II Cancer Drug Candidate, Closing on $9.7M in Financing, and Filing of Form 10 Registration Statement

Monopar Therapeutics today announced the acquisition of GPX-150 from privately held Gem Pharmaceuticals concurrent with $9.7M of new financing.

November 14, 2017

·

5 min read

Enleofen Release: Publication in Leading Scientific Journal ‘Nature’ by Singaporean Research Team Highlights Groundbreaking New Target for the Treatment of Cardiovascular Fibrosis

The work, led by Stuart Cook and Sebastian Schafer, was performed by a team of scientists at Duke-NUS and NHCS.

November 14, 2017

·

2 min read

Business

BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission

Mrs. Wittwer brings to BioSig over 15 years of experience in FDA regulatory affairs on behalf of public and private companies.

November 14, 2017

·

4 min read

CEVEC Has Been Granted a New CAPGo Technology Patent And Reinforces its Leading Role in Production of Recombinant Proteins Previously Out of Reach

The patent broadly protects genetically engineered cell lines for the production of O-glycosylated proteins with a significantly improved plasma half-life.

November 14, 2017

·

3 min read

Business

Pressure BioSciences, Inc. Reports Third Quarter 2017 Financial Results and Provides Business Update

Total Revenue increased 21%, from $535,334 in Q3 2016 to $646,061

November 14, 2017

·

20 min read

Business

Celsion Corporation Reports Third Quarter 2017 Financial Results and Provides Business Update

For the quarter ended September 30, 2017, Celsion reported a net loss of $5.7 million, or $(0.70) per share, compared to a net loss of $6.4 million, or $(3.22) per share, in the same period of 2016

November 14, 2017

·

18 min read

Business

Mateon Provides Corporate Update and Reports Third Quarter 2017 Financial Results

For the three months ended September 30, 2017, Mateon reported a net loss of $3.5 million, compared to a net loss of $3.2 million for the three months ended September 30, 2016.

November 14, 2017

·

4 min read